Reichenbach J - Search Results

1

A 19-month-old Boy With Refractory Cervical Adenitis.

Schneider A, Ranza E, Diana A, Laurent M, Rougemont AL, Hauri M, Reichenbach J, Blanchard-Rohner G. Schneider A, et al. Among authors: reichenbach j. Pediatr Infect Dis J. 2019 Oct;38(10):1071. doi: 10.1097/INF.0000000000002336. Pediatr Infect Dis J. 2019. PMID: 31568146 No abstract available.

2

Immunogenicity of the seven valent pneumococcal conjugate vaccine in patients with ataxia-telangiectasia.

Schubert R, Reichenbach J, Rose M, Zielen S. Schubert R, et al. Among authors: reichenbach j. Pediatr Infect Dis J. 2004 Mar;23(3):269-70. doi: 10.1097/01.inf.0000115737.35353.55. Pediatr Infect Dis J. 2004. PMID: 15014308

3

CRISPR/Cas9-generated p47^phox-deficient cell line for Chronic Granulomatous Disease gene therapy vector development.

Wrona D, Siler U, Reichenbach J. Wrona D, et al. Among authors: reichenbach j. Sci Rep. 2017 Mar 13;7:44187. doi: 10.1038/srep44187. Sci Rep. 2017. PMID: 28287132 Free PMC article.

4

High Levels of IL-18 and IFN-γ in Chronically Inflamed Tissue in Chronic Granulomatous Disease.

Meda Spaccamela V, Valencia RG, Pastukhov O, Duppenthaler A, Dettmer MS, Erb J, Steiner UC, Hillinger S, Speckmann C, Ehl S, Reichenbach J, Siler U. Meda Spaccamela V, et al. Among authors: reichenbach j. Front Immunol. 2019 Oct 18;10:2236. doi: 10.3389/fimmu.2019.02236. eCollection 2019. Front Immunol. 2019. PMID: 31681257 Free PMC article. Clinical Trial.

5

TALEN-mediated functional correction of X-linked chronic granulomatous disease in patient-derived induced pluripotent stem cells.

Dreyer AK, Hoffmann D, Lachmann N, Ackermann M, Steinemann D, Timm B, Siler U, Reichenbach J, Grez M, Moritz T, Schambach A, Cathomen T. Dreyer AK, et al. Among authors: reichenbach j. Biomaterials. 2015 Nov;69:191-200. doi: 10.1016/j.biomaterials.2015.07.057. Epub 2015 Aug 3. Biomaterials. 2015. PMID: 26295532

6

Modern management of phagocyte defects.

Lanini LL, Prader S, Siler U, Reichenbach J. Lanini LL, et al. Among authors: reichenbach j. Pediatr Allergy Immunol. 2017 Mar;28(2):124-134. doi: 10.1111/pai.12654. Epub 2016 Oct 13. Pediatr Allergy Immunol. 2017. PMID: 27612320 Review.

7

Restoration of NET formation by gene therapy in CGD controls aspergillosis.

Bianchi M, Hakkim A, Brinkmann V, Siler U, Seger RA, Zychlinsky A, Reichenbach J. Bianchi M, et al. Among authors: reichenbach j. Blood. 2009 Sep 24;114(13):2619-22. doi: 10.1182/blood-2009-05-221606. Epub 2009 Jun 18. Blood. 2009. PMID: 19541821 Free PMC article.

8

Restoration of anti-Aspergillus defense by neutrophil extracellular traps in human chronic granulomatous disease after gene therapy is calprotectin-dependent.

Bianchi M, Niemiec MJ, Siler U, Urban CF, Reichenbach J. Bianchi M, et al. Among authors: reichenbach j. J Allergy Clin Immunol. 2011 May;127(5):1243-52.e7. doi: 10.1016/j.jaci.2011.01.021. Epub 2011 Mar 3. J Allergy Clin Immunol. 2011. PMID: 21376380

9

Elevated oxidative stress in patients with ataxia telangiectasia.

Reichenbach J, Schubert R, Schindler D, Müller K, Böhles H, Zielen S. Reichenbach J, et al. Antioxid Redox Signal. 2002 Jun;4(3):465-9. doi: 10.1089/15230860260196254. Antioxid Redox Signal. 2002. PMID: 12215213

10

Extracerebellar MRI-lesions in ataxia telangiectasia go along with deficiency of the GH/IGF-1 axis, markedly reduced body weight, high ataxia scores and advanced age.

Kieslich M, Hoche F, Reichenbach J, Weidauer S, Porto L, Vlaho S, Schubert R, Zielen S. Kieslich M, et al. Among authors: reichenbach j. Cerebellum. 2010 Jun;9(2):190-7. doi: 10.1007/s12311-009-0138-0. Cerebellum. 2010. PMID: 19898915

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

411 results

Search Page